Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-774-7 | CAS number: 99-63-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 3.94 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 200
- Dose descriptor starting point:
- NOAEL
- Value:
- 447 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 789.9 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Relevant dose-descriptor
Value: 447 mg/kg (NOAEL). This is the concentration where no significant adverse effects were seen in a sub-chronic oral toxicity study.
Modification of starting point for rat respiratory volume (Allometric scaling)
Value: 0.38 m3/kg bw (rat 8-hour respiratory volume). A modification of starting point for rat respiratory volume was applied per REACH guidance R.8.4.2.
Modification of starting point for differences in respiratory volumes
Value: 0.67 (6.7 m3/10 m3). A modification was applied to account for the increased respiratory volumes in active workers as compared to individuals at rest per REACH guidance R.8.4.2.
- AF for dose response relationship:
- 1
- Justification:
- A factor of 1 is appropriate since the dose descriptor is a NOAEL.
- AF for differences in duration of exposure:
- 2
- Justification:
- This is a default assessment factor for a sub-chronic study per REACH Guidance R.8.4.3.1.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- A factor of 1 is appropriate since the adjusted start point was via mg/m3 (inhalation) and thus this assessment factor is not applicable per REACH guidance R.8.4.3.1.
- AF for other interspecies differences:
- 2.5
- Justification:
- A default factor of 2.5 is appropriate per REACH guidance R.8.4.3.1.
- AF for intraspecies differences:
- 5
- Justification:
- This is a default assessment factor for workers per REACH Guidance R.8.4.3.1.
- AF for the quality of the whole database:
- 4
- Justification:
- A factor of 4 is appropriate because of the lack of repeat dose inhalation data warrants an uncertainty factor of greater than 1.
- AF for remaining uncertainties:
- 2
- Justification:
- Route-to-route extrapolation: A factor of 2 is appropriate per REACH guidance R.8.4.2 (oral to inhalation).
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 4.47 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 100
- Dose descriptor starting point:
- NOAEL
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 447 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
Relevant dose-descriptor
Value: 447 mg/kg (NOAEL). This is the concentration where no significant adverse effects were seen in a sub-chronic oral toxicity study.
- AF for dose response relationship:
- 1
- Justification:
- A factor of 1 is appropriate since the dose descriptor is a NOAEL.
- AF for differences in duration of exposure:
- 2
- Justification:
- This is a default assessment factor for a sub-chronic study per REACH Guidance R.8.4.3.1.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- A factor of 4 is appropriate since the adjusted start point was via mg/kg per REACH guidance 8.4.3.1.
- AF for other interspecies differences:
- 2.5
- Justification:
- A default factor of 2.5 is appropriate per REACH guidance R.8.4.3.1.
- AF for intraspecies differences:
- 5
- Justification:
- This is a default assessment factor for workers per REACH Guidance R.8.4.3.1.
- AF for the quality of the whole database:
- 1
- Justification:
- A high quality, robust toxicity database exists for this substance.
- AF for remaining uncertainties:
- 1
- Justification:
- Route-to-route extrapolation: A factor of 1 is appropriate since the animal exposure was via ingestion.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
- Explanation for the modification of the dose descriptor starting point:
No hazard identified, therefore no DNEL was calculated.
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- high hazard (no threshold derived)
Additional information - workers
Potential worker exposure would likely occur via the dermal or inhalation routes.
This substance is classified as harmful via the dermal route and toxic via the inhalation route under REACH regulations and guidance. The rabbit dermal LD50 value is 1410 mg/kg. The rat 4-hour inhalation LC50 value for the structurally similar substance, terephthaloyl dichloride (CAS 100-20-9), which was used as a surrogate for acute inhalation data, is 700 mg/m3.
Male and female rats were fed daily for 13 weeks at levels of 0.5, 1.6, and 5% of the test substance in the diet. Following the first week of the study the weight gains of the rats were examined. It was concluded that the 5% dose level would not permit growth. Therefore, the high dose was reduced to 3%. An increase in crystalluria was observed. Examination of organs at necropsy revealed mild to moderate hyperplasia in kidneys in the highest dosage level. Based on this information, the 90 -day rat oral NOAEL was identified as 0.5% (calculated as 447 mg/kg-day for males and 474 mg/kg-day for females).
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.97 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 400
- Dose descriptor starting point:
- NOAEL
- Value:
- 447 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 388.7 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Relevant dose-descriptor
Value: 447 mg/kg (NOAEL). This is the concentration where no significant adverse effects were seen in a sub-chronic oral toxicity study.
Modification of starting point for rat respiratory volume (Allometric scaling)
Value: 1.15 m3/kg bw (rat 24-hour respiratory volume). A modification of starting point for rat respiratory volume was applied per REACH guidance R.8.4.2.
- AF for dose response relationship:
- 1
- Justification:
- A factor of 1 is appropriate since the dose descriptor is a NOAEL.
- AF for differences in duration of exposure:
- 2
- Justification:
- This is a default assessment factor for a sub-chronic study per REACH Guidance R.8.4.3.1.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- A factor of 1 is appropriate since the adjusted start point was via mg/m3(inhalation) and thus this assessment factor is not applicable per REACH guidance R.8.4.3.1.
- AF for other interspecies differences:
- 2.5
- Justification:
- A default factor of 2.5 is appropriate per REACH guidance R.8.4.3.1.
- AF for intraspecies differences:
- 10
- Justification:
- This is a default assessment factor for the general population per REACH Guidance R.8.4.3.1.
- AF for the quality of the whole database:
- 4
- Justification:
- A factor of 4 is appropriate because of the lack of repeat dose inhalation data warrants an uncertainty factor of greater than 1.
- AF for remaining uncertainties:
- 2
- Justification:
- Route-to-route extrapolation: A factor of 2 is appropriate per REACH guidance R.8.4.2 (oral to inhalation).
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2.24 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 200
- Dose descriptor starting point:
- NOAEL
- Value:
- 447 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
Relevant dose-descriptor
Value: 447 mg/kg (NOAEL). This is the concentration where no significant adverse effects were seen in a sub-chronic oral toxicity study.
- AF for dose response relationship:
- 1
- Justification:
- A factor of 1 is appropriate since the dose descriptor is a NOAEL.
- AF for differences in duration of exposure:
- 2
- Justification:
- This is a default assessment factor for a sub-chronic study per REACH Guidance R.8.4.3.1.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- A factor of 4 is appropriate since the adjusted start point was via mg/kg per REACH guidance 8.4.3.1.
- AF for other interspecies differences:
- 2.5
- Justification:
- A default factor of 2.5 is appropriate per REACH guidance R.8.4.3.1.
- AF for intraspecies differences:
- 10
- Justification:
- This is a default assessment factor for the general population per REACH Guidance R.8.4.3.1.
- AF for the quality of the whole database:
- 1
- Justification:
- A high quality, robust toxicity database exists for this substance.
- AF for remaining uncertainties:
- 1
- Justification:
- Route-to-route extrapolation: A factor of 1 is appropriate since the animal expoure was via ingestion.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2.24 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 200
- Dose descriptor starting point:
- NOAEL
- Value:
- 447 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
Relevant dose-descriptor
Value: 447 mg/kg (NOAEL). This is the concentration where no significant adverse effects were seen in a sub-chronic oral toxicity study.
- AF for dose response relationship:
- 1
- Justification:
- A factor of 1 is appropriate since the dose descriptor is a NOAEL.
- AF for differences in duration of exposure:
- 2
- Justification:
- This is a default assessment factor for a sub-chronic study per REACH Guidance R.8.4.3.1.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- A factor of 4 is appropriate since the adjusted start point was via mg/kg per REACH guidance 8.4.3.1.
- AF for other interspecies differences:
- 2.5
- Justification:
- A default factor of 2.5 is appropriate per REACH guidance R.8.4.3.1.
- AF for intraspecies differences:
- 10
- Justification:
- This is a default assessment factor for the general population per REACH Guidance R.8.4.3.1.
- AF for the quality of the whole database:
- 1
- Justification:
- A high quality, robust toxicity database exists for this substance.
- AF for remaining uncertainties:
- 1
- Justification:
- Route-to-route extrapolation: A factor of 1 is appropriate since the animal exposure was via ingestion.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- high hazard (no threshold derived)
Additional information - General Population
Potential general population
exposure would likely occur via the dermal, oral, or inhalation routes.
This substance is classified as
harmful via the dermal route and toxic via the inhalation route under
REACH regulations and guidance. The rabbit dermal LD50 value is 1410
mg/kg. The rat 4-hour inhalation LC50 value for the structurally similar
substance, terephthaloyl dichloride (CAS 100-20-9), which was used as a
surrogate for acute inhalation data, is 700 mg/m3.
Male and female rats were fed
daily for 13 weeks at levels of 0.5, 1.6, and 5% of the test substance
in the diet. Following the first week of the study the weight gains of
the rats were examined. It was concluded that the 5% dose level would
not permit growth. Therefore the high dose was reduced to 3%. An
increase in crystalluria was observed. Examination of organs at necropsy
revealed mild to moderate hyperplasia in kidneys in the highest dosage
level. Based on this information, the 90 -day rat oral NOAEL was
identified as 0.5% (calculated as 447 mg/kg-day for males and 474
mg/kg-day for females).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.